Prenatal anesthetic exposure and offspring neurodevelopmental outcomes-A narrative review

Nannan Zhou1, Shuang Liang1, Xinying Yue1

  • 1Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Neurology
|April 17, 2023
PubMed

Insights

Prenatal anesthesia exposure (PAE) effects on child neurodevelopment are unclear. Animal studies show PAE causes neurotoxicity, but clinical studies face challenges with confounding factors impacting long-term outcomes.

Area of Science:

  • Anesthesiology
  • Neuroscience
  • Developmental Pediatrics

Background:

  • Anesthesia use during pregnancy is common.
  • Long-term neurodevelopmental effects of prenatal anesthesia exposure (PAE) in offspring require clarification.
  • Animal studies indicate PAE can lead to neurotoxicity, including histomorphological changes and impaired learning and memory.

Purpose of the Study:

  • To review current research on PAE and offspring neurodevelopment.
  • To discuss findings from both animal experimental and clinical studies.
  • To introduce methods for assessing child neurodevelopment and potential confounding factors.

Main Methods:

  • This is a narrative review.
  • It synthesizes data from preclinical animal research.
  • It analyzes findings from regional birth cohort studies using specialized questionnaires and scales.

Main Results:

  • Animal models demonstrate that in utero anesthetic exposure can induce neurotoxic effects in newborns.
  • Clinical studies, often database-based, are convenient but complicated by long time intervals between exposure and outcome assessment.
  • Numerous confounding factors in clinical studies can significantly influence offspring neurodevelopment, potentially overshadowing the impact of PAE.

Conclusions:

  • The long-term neurodevelopmental consequences of PAE remain an area needing further investigation.
  • Clinical research on PAE is challenged by the complexity of isolating effects from confounding variables.
  • Future research should carefully consider and control for confounding factors when assessing neurodevelopmental outcomes after PAE.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
170
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
464